These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24406931)

  • 1. Cytokine-driven beta-cell production in vivo.
    Worchel HN; Magnuson MA
    Nat Biotechnol; 2014 Jan; 32(1):63-4. PubMed ID: 24406931
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice.
    Baeyens L; Lemper M; Leuckx G; De Groef S; Bonfanti P; Stangé G; Shemer R; Nord C; Scheel DW; Pan FC; Ahlgren U; Gu G; Stoffers DA; Dor Y; Ferrer J; Gradwohl G; Wright CV; Van de Casteele M; German MS; Bouwens L; Heimberg H
    Nat Biotechnol; 2014 Jan; 32(1):76-83. PubMed ID: 24240391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemia.
    Lemper M; De Groef S; Stangé G; Baeyens L; Heimberg H
    Diabetologia; 2016 Sep; 59(9):1948-58. PubMed ID: 27318836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance.
    Rezende LF; Santos GJ; Santos-Silva JC; Carneiro EM; Boschero AC
    Diabetologia; 2012 May; 55(5):1495-504. PubMed ID: 22349107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New hormone stimulates pancreatic β-cell proliferation.
    Gilbert JA
    Lancet Diabetes Endocrinol; 2013 Aug; 1 Suppl 1():s12. PubMed ID: 24622586
    [No Abstract]   [Full Text] [Related]  

  • 6. A natural DYRK1A inhibitor as a potential stimulator for β-cell proliferation in diabetes.
    Zheng M; Zhang Q; Zhang C; Wu C; Yang K; Song Z; Wang Q; Li C; Zhou Y; Chen J; Li H; Chen L
    Clin Transl Med; 2021 Jul; 11(7):e494. PubMed ID: 34323401
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin Therapy, Insulin Resistance and Vascular Dysfunction.
    Vázquez MC; Sobrevia L
    Curr Vasc Pharmacol; 2019; 17(5):429-431. PubMed ID: 31418345
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of diabetes treatment.
    Petersen JS
    Ann Endocrinol (Paris); 2008 Apr; 69(2):166-7. PubMed ID: 18440491
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.
    Rezende LF; Santos GJ; Carneiro EM; Boschero AC
    J Biol Chem; 2012 Dec; 287(50):41628-39. PubMed ID: 23038263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative pharmacology for diabetes mellitus.
    Furth ME; Christ GJ
    Mol Interv; 2009 Aug; 9(4):171-4. PubMed ID: 19720749
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early insulinization to prevent diabetes progression.
    Raz I; Mosenzon O
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S190-7. PubMed ID: 23882045
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy.
    Wang Z; York NW; Nichols CG; Remedi MS
    Cell Metab; 2014 May; 19(5):872-82. PubMed ID: 24746806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
    Mihailidou C; Chatzistamou I; Papavassiliou AG; Kiaris H
    Pflugers Arch; 2016 Nov; 468(11-12):1957-1968. PubMed ID: 27757583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.
    Kumar K; Suebsuwong C; Wang P; Garcia-Ocana A; Stewart AF; DeVita RJ
    J Med Chem; 2021 Mar; 64(6):2901-2922. PubMed ID: 33682417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products Modulating Autophagy Pathway Against the Pathogenesis of Diabetes Mellitus.
    Li L; Qi J; Li H
    Curr Drug Targets; 2019; 20(1):96-110. PubMed ID: 30047328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones and slowing the progression of diabetes.
    Jackson T; Aquilina A; Bloom J; Guerra-Garcia H; Salom I; Tzeel A; Kaminsky R
    Manag Care Interface; 2007 Aug; 20(8):29-34. PubMed ID: 18041348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factors and medium hyperglycemia induce Sox9+ ductal cell differentiation into β cells in mice with reversal of diabetes.
    Zhang M; Lin Q; Qi T; Wang T; Chen CC; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):650-5. PubMed ID: 26733677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).
    Galal O; Podlogar J; Verspohl EJ
    J Pharm Pharmacol; 2013 Feb; 65(2):253-63. PubMed ID: 23278693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin oscillations--clinically important rhythm. Antidiabetics should increase the pulsative component of the insulin release].
    Hellman B; Gylfe E; Grapengiesser E; Dansk H; Salehi A
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2236-9. PubMed ID: 17822201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.